What is the proper usage and dosage of Norethindrone acetate (synthetic progestin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norethindrone Acetate: Proper Usage and Dosage Guidelines

Norethindrone acetate dosage should be tailored based on the specific indication, with 2.5-10 mg daily for menstrual disorders and 5-15 mg daily for endometriosis. 1

Indications and Dosing

Secondary Amenorrhea and Abnormal Uterine Bleeding

  • 2.5 to 10 mg daily for 5 to 10 days to produce secretory transformation of the endometrium that has been adequately primed with estrogen 1
  • Progestin withdrawal bleeding typically occurs within 3-7 days after discontinuing therapy 1
  • Patients with recurrent abnormal uterine bleeding may benefit from planned menstrual cycling with norethindrone acetate 1

Endometriosis

  • Initial dosage: 5 mg daily for two weeks 1
  • Increase by 2.5 mg daily every two weeks until reaching 15 mg daily 1
  • Maintain therapy at 15 mg daily for six to nine months or until breakthrough bleeding requires temporary discontinuation 1

Hormone Replacement Therapy

  • When combined with estradiol (0.05 mg/day), norethindrone acetate doses of 0.5-1.0 mg daily for 12 days each month are effective 2
  • For continuous combined therapy with estradiol (1 mg), doses as low as 0.1 mg daily effectively prevent endometrial hyperplasia 3

Contraception

  • For contraceptive purposes, microdose norethindrone (0.35 mg) is taken daily without interruption 4
  • In combined hormonal contraceptives, norethindrone acetate is paired with ethinyl estradiol 5
  • The 24-day regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg shows better bleeding profile than 21-day regimens 6

Contraindications

Norethindrone acetate is contraindicated in patients with:

  • Breast cancer or other estrogen/progestin-sensitive cancers 5
  • Active or history of arterial thromboembolic disease (stroke or myocardial infarction) 5
  • Deep vein thrombosis, thromboembolic disease, or pulmonary embolism 5
  • Undiagnosed genital bleeding 5
  • Hepatic adenomas, carcinomas, or active liver disease 5
  • Pregnancy (Category X) 5

Adverse Effects

Common adverse effects include:

  • Central nervous system: Depression, headache, mood changes, nervousness 5
  • Endocrine: Amenorrhea, breakthrough bleeding, breast pain/tenderness, fluid retention 5
  • Gastrointestinal: Abdominal cramps, nausea, weight changes, vomiting 5
  • Skin: Chloasma, melasma, erythema nodosum 5
  • Cardiovascular: Edema, varicose veins aggravation 5

Drug Interactions

Norethindrone acetate effectiveness may be reduced by:

  • Certain antibiotics (cephalosporins, macrolides, penicillins, tetracyclines) 5
  • Anticonvulsants (barbiturates, carbamazepine, phenytoin, topiramate) 5
  • Rifampin or rifabutin therapy 5
  • St. John's wort 5
  • HIV protease inhibitors 5

Monitoring

  • Baseline assessment: Pregnancy status, blood pressure 5
  • Ongoing monitoring: Regular assessment of health status and blood pressure 5

Special Considerations

In Fertility Treatment

  • Norethindrone acetate (10 mg/day) can be used to program ovarian stimulation in IVF/GIFT cycles 7
  • Administration is oral, simple, and inexpensive, with ovarian response to gonadotropin stimulation not affected by norethindrone acetate 7

In Acne Treatment

  • Norethindrone acetate combined with ethinyl estradiol is FDA-approved for acne treatment in women who desire oral contraception 5
  • The mechanism of action in acne treatment is based on antiandrogenic properties, decreasing androgen production and increasing sex hormone-binding globulin 5

Clinical Pearls

  • When used for menstrual disorders, withdrawal bleeding typically occurs 3-7 days after discontinuation 1
  • For endometriosis, gradual dose escalation helps minimize side effects while achieving therapeutic benefit 1
  • In hormone replacement therapy, continuous low-dose norethindrone acetate (as low as 0.1 mg) with estradiol effectively prevents endometrial hyperplasia 3
  • The safety profile of norethindrone acetate in women with premature ovarian insufficiency may be worse in terms of blood pressure and renal function compared to natural micronized progesterone 5
  • Extended regimens (24-day active pills vs. 21-day) may reduce breakthrough bleeding and provide better cycle control 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.